Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
fda approvals 2022 | 0.92 | 0.8 | 3887 | 60 | 18 |
fda | 0.91 | 0.9 | 8340 | 97 | 3 |
approvals | 1.4 | 0.7 | 9081 | 86 | 9 |
2022 | 1.14 | 0.5 | 837 | 88 | 4 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda approvals 2022 | 1.22 | 0.9 | 5930 | 87 |
fda approvals 2020 | 0.88 | 0.2 | 4009 | 71 |
fda approvals 2023 | 1.82 | 0.4 | 6742 | 48 |
fda approvals 2021 | 1.94 | 0.1 | 3406 | 81 |
fda approvals 2024 | 0.63 | 0.1 | 1777 | 55 |
fda drug approvals 2022 | 1.2 | 0.6 | 9864 | 95 |
fda new drug approvals 2022 | 1.04 | 0.7 | 4482 | 87 |
pacritinib fda approval 2022 | 1.02 | 0.8 | 669 | 80 |
teplizumab fda approval 2022 | 0.55 | 0.7 | 7965 | 35 |
fda new drug therapy approvals 2022 | 1.89 | 0.9 | 3414 | 22 |
tirzepatide fda approval 2022 | 0.98 | 0.2 | 1593 | 53 |